Skip to main content
OpenTrials

Clinical trial condition

Lung Cancer Metastatic

Explore clinical trials studying Lung Cancer Metastatic. Study availability and eligibility vary by location and protocol.

27 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Lung Cancer Metastatic trial results

Active, not recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, not recruiting

NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

NCT04986670

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • The James Cancer Hospital Columbus, Ohio, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT03184571

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +14 more
Locations
  • Dartmouth-Hitchcock Medical Center (DHMC) Lebanon, New Hampshire, United States
  • Medical College of Wisconsin, 9200 W Wisconsin Avenue Milwaukee, Wisconsin, United States
  • Radiumhospitalet, Oslo University Hospital PB Oslo, Norway
  • Hospital Universitari Germans Trias i Pujol-ICO Barcelona, Badalona, Spain
View all 13 locations
View Trial Details
Completed

A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.

NCT03755102

Conditions
EGFR Gene Mutation, Lung Cancer, Lung Cancer Metastatic, +7 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details

Related conditions